APO Research
Talk to an analyst

APO RESEARCH · REPORT

Irbesartan

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Irbesartan Market Analysis and Forecast 2026-2032

30 December 2025211 pages

Choose your research edition.

Industry ResearchIrbesartan Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal Irbesartan Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Irbesartan Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Irbesartan Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Irbesartan Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Irbesartan market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Irbesartan is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Irbesartan is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Irbesartan is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Irbesartan is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Irbesartan include Angita Pharma, Apotex, Auro Pharma, Avanstra, BMS, Hanall, Shionogi, Sumitomo Dainippon Pharma and Taj Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Irbesartan, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Irbesartan, also provides the sales of main regions and countries. Of the upcoming market potential for Irbesartan, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Irbesartan sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Irbesartan market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Irbesartan sales, projected growth trends, production technology, application and end-user industry.

Irbesartan Segment by Company

Angita Pharma

Apotex

Auro Pharma

Avanstra

BMS

Hanall

Shionogi

Sumitomo Dainippon Pharma

Taj Pharmaceuticals

Verdant Life Sciences

Jiangsu Hengrui Medicine

Jiangsu Wangao Pharmaceutical

CTTQ

Novartis

Sanofi

Teva

Tianjin Huairen Pharmaceutical

Xiansheng Pharmaceutical

Yuanhe Pharmaceutical

Zhejiang Ainuo Pharmaceutical

Zhejiang Huahai Pharmaceutical

Zhuhai Rundu Pharma

Irbesartan Segment by Type

Combination Drugs

Prescribed Drugs

Irbesartan Segment by Application

Heart Failure

Fibrous Fibrillation

Kidney Disease

Hyperlipidemia

High Blood Pressure

Other

Irbesartan Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Irbesartan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Irbesartan and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Irbesartan.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Irbesartan in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Irbesartan manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Irbesartan sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Irbesartan Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Combination Drugs Major Manufacturers Table 3. Prescribed Drugs Major Manufacturers Table 4. Global Irbesartan Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Heart Failure Major Manufacturers Table 6. Fibrous Fibrillation Major Manufacturers Table 7. Kidney Disease Major Manufacturers Table 8. Hyperlipidemia Major Manufacturers Table 9. High Blood Pressure Major Manufacturers Table 10. Other Major Manufacturers Table 11. Irbesartan Industry Trends Table 12. Irbesartan Industry Drivers Table 13. Irbesartan Industry Opportunities and Challenges Table 14. Irbesartan Industry Restraints Table 15. Global Irbesartan Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Irbesartan Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Irbesartan Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Irbesartan Revenue Market Share by Region (2021-2026) Table 19. Global Irbesartan Revenue Market Share by Region (2027-2032) Table 20. Global Irbesartan Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Kg) Table 21. Global Irbesartan Sales by Region (2021-2026) & (Kg) Table 22. Global Irbesartan Sales by Region (2027-2032) & (Kg) Table 23. Global Irbesartan Sales Market Share by Region (2021-2026) Table 24. Global Irbesartan Sales Market Share by Region (2027-2032) Table 25. Global Irbesartan Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Irbesartan Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Irbesartan Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Irbesartan Sales Market Share by Manufacturers (2021-2026) Table 29. Global Irbesartan Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 30. Global Irbesartan Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Irbesartan Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Irbesartan Manufacturers, Product Type & Application Table 33. Global Irbesartan Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Irbesartan by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Irbesartan Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Irbesartan Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Irbesartan Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Irbesartan Revenue Market Share by Type (2021-2026) Table 40. Global Irbesartan Revenue Market Share by Type (2027-2032) Table 41. Global Irbesartan Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 42. Global Irbesartan Sales by Type (2021-2026) & (Kg) Table 43. Global Irbesartan Sales by Type (2027-2032) & (Kg) Table 44. Global Irbesartan Sales Market Share by Type (2021-2026) Table 45. Global Irbesartan Sales Market Share by Type (2027-2032) Table 46. Global Irbesartan Price by Type (2021-2026) & (US$/Kg) Table 47. Global Irbesartan Price by Type (2027-2032) & (US$/Kg) Table 48. Global Irbesartan Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Irbesartan Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Irbesartan Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Irbesartan Revenue Market Share by Application (2021-2026) Table 52. Global Irbesartan Revenue Market Share by Application (2027-2032) Table 53. Global Irbesartan Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 54. Global Irbesartan Sales by Application (2021-2026) & (Kg) Table 55. Global Irbesartan Sales by Application (2027-2032) & (Kg) Table 56. Global Irbesartan Sales Market Share by Application (2021-2026) Table 57. Global Irbesartan Sales Market Share by Application (2027-2032) Table 58. Global Irbesartan Price by Application (2021-2026) & (US$/Kg) Table 59. Global Irbesartan Price by Application (2027-2032) & (US$/Kg) Table 60. Angita Pharma Company Information Table 61. Angita Pharma Business Overview Table 62. Angita Pharma Irbesartan Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 63. Angita Pharma Irbesartan Product Portfolio Table 64. Angita Pharma Recent Development Table 65. Apotex Company Information Table 66. Apotex Business Overview Table 67. Apotex Irbesartan Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 68. Apotex Irbesartan Product Portfolio Table 69. Apotex Recent Development Table 70. Auro Pharma Company Information Table 71. Auro Pharma Business Overview Table 72. Auro Pharma Irbesartan Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 73. Auro Pharma Irbesartan Product Portfolio Table 74. Auro Pharma Recent Development Table 75. Avanstra Company Information Table 76. Avanstra Business Overview Table 77. Avanstra Irbesartan Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 78. Avanstra Irbesartan Product Portfolio Table 79. Avanstra Recent Development Table 80. BMS Company Information Table 81. BMS Business Overview Table 82. BMS Irbesartan Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 83. BMS Irbesartan Product Portfolio Table 84. BMS Recent Development Table 85. Hanall Company Information Table 86. Hanall Business Overview Table 87. Hanall Irbesartan Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 88. Hanall Irbesartan Product Portfolio Table 89. Hanall Recent Development Table 90. Shionogi Company Information Table 91. Shionogi Business Overview Table 92. Shionogi Irbesartan Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 93. Shionogi Irbesartan Product Portfolio Table 94. Shionogi Recent Development Table 95. Sumitomo Dainippon Pharma Company Information Table 96. Sumitomo Dainippon Pharma Business Overview Table 97. Sumitomo Dainippon Pharma Irbesartan Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 98. Sumitomo Dainippon Pharma Irbesartan Product Portfolio Table 99. Sumitomo Dainippon Pharma Recent Development Table 100. Taj Pharmaceuticals Company Information Table 101. Taj Pharmaceuticals Business Overview Table 102. Taj Pharmaceuticals Irbesartan Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 103. Taj Pharmaceuticals Irbesartan Product Portfolio Table 104. Taj Pharmaceuticals Recent Development Table 105. Verdant Life Sciences Company Information Table 106. Verdant Life Sciences Business Overview Table 107. Verdant Life Sciences Irbesartan Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 108. Verdant Life Sciences Irbesartan Product Portfolio Table 109. Verdant Life Sciences Recent Development Table 110. Jiangsu Hengrui Medicine Company Information Table 111. Jiangsu Hengrui Medicine Business Overview Table 112. Jiangsu Hengrui Medicine Irbesartan Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 113. Jiangsu Hengrui Medicine Irbesartan Product Portfolio Table 114. Jiangsu Hengrui Medicine Recent Development Table 115. Jiangsu Wangao Pharmaceutical Company Information Table 116. Jiangsu Wangao Pharmaceutical Business Overview Table 117. Jiangsu Wangao Pharmaceutical Irbesartan Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 118. Jiangsu Wangao Pharmaceutical Irbesartan Product Portfolio Table 119. Jiangsu Wangao Pharmaceutical Recent Development Table 120. CTTQ Company Information Table 121. CTTQ Business Overview Table 122. CTTQ Irbesartan Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 123. CTTQ Irbesartan Product Portfolio Table 124. CTTQ Recent Development Table 125. Novartis Company Information Table 126. Novartis Business Overview Table 127. Novartis Irbesartan Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 128. Novartis Irbesartan Product Portfolio Table 129. Novartis Recent Development Table 130. Sanofi Company Information Table 131. Sanofi Business Overview Table 132. Sanofi Irbesartan Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 133. Sanofi Irbesartan Product Portfolio Table 134. Sanofi Recent Development Table 135. Teva Company Information Table 136. Teva Business Overview Table 137. Teva Irbesartan Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 138. Teva Irbesartan Product Portfolio Table 139. Teva Recent Development Table 140. Tianjin Huairen Pharmaceutical Company Information Table 141. Tianjin Huairen Pharmaceutical Business Overview Table 142. Tianjin Huairen Pharmaceutical Irbesartan Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 143. Tianjin Huairen Pharmaceutical Irbesartan Product Portfolio Table 144. Tianjin Huairen Pharmaceutical Recent Development Table 145. Xiansheng Pharmaceutical Company Information Table 146. Xiansheng Pharmaceutical Business Overview Table 147. Xiansheng Pharmaceutical Irbesartan Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 148. Xiansheng Pharmaceutical Irbesartan Product Portfolio Table 149. Xiansheng Pharmaceutical Recent Development Table 150. Yuanhe Pharmaceutical Company Information Table 151. Yuanhe Pharmaceutical Business Overview Table 152. Yuanhe Pharmaceutical Irbesartan Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 153. Yuanhe Pharmaceutical Irbesartan Product Portfolio Table 154. Yuanhe Pharmaceutical Recent Development Table 155. Zhejiang Ainuo Pharmaceutical Company Information Table 156. Zhejiang Ainuo Pharmaceutical Business Overview Table 157. Zhejiang Ainuo Pharmaceutical Irbesartan Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 158. Zhejiang Ainuo Pharmaceutical Irbesartan Product Portfolio Table 159. Zhejiang Ainuo Pharmaceutical Recent Development Table 160. Zhejiang Huahai Pharmaceutical Company Information Table 161. Zhejiang Huahai Pharmaceutical Business Overview Table 162. Zhejiang Huahai Pharmaceutical Irbesartan Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 163. Zhejiang Huahai Pharmaceutical Irbesartan Product Portfolio Table 164. Zhejiang Huahai Pharmaceutical Recent Development Table 165. Zhuhai Rundu Pharma Company Information Table 166. Zhuhai Rundu Pharma Business Overview Table 167. Zhuhai Rundu Pharma Irbesartan Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 168. Zhuhai Rundu Pharma Irbesartan Product Portfolio Table 169. Zhuhai Rundu Pharma Recent Development Table 170. North America Irbesartan Revenue by Type (2021-2026) & (US$ Million) Table 171. North America Irbesartan Revenue by Type (2027-2032) & (US$ Million) Table 172. North America Irbesartan Sales by Type (2021-2026) & (Kg) Table 173. North America Irbesartan Sales by Type (2027-2032) & (Kg) Table 174. North America Irbesartan Sales Price by Type (2021-2026) & (US$/Kg) Table 175. North America Irbesartan Sales Price by Type (2027-2032) & (US$/Kg) Table 176. North America Irbesartan Revenue by Application (2021-2026) & (US$ Million) Table 177. North America Irbesartan Revenue by Application (2027-2032) & (US$ Million) Table 178. North America Irbesartan Sales by Application (2021-2026) & (Kg) Table 179. North America Irbesartan Sales by Application (2027-2032) & (Kg) Table 180. North America Irbesartan Sales Price by Application (2021-2026) & (US$/Kg) Table 181. North America Irbesartan Sales Price by Application (2027-2032) & (US$/Kg) Table 182. North America Irbesartan Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. North America Irbesartan Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 184. North America Irbesartan Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 185. North America Irbesartan Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 186. North America Irbesartan Sales by Country (2021-2026) & (Kg) Table 187. North America Irbesartan Sales by Country (2027-2032) & (Kg) Table 188. North America Irbesartan Sales Price by Country (2021-2026) & (US$/Kg) Table 189. North America Irbesartan Sales Price by Country (2027-2032) & (US$/Kg) Table 190. United States Irbesartan Revenue (2021-2032) & (US$ Million) Table 191. Canada Irbesartan Revenue (2021-2032) & (US$ Million) Table 192. Europe Irbesartan Revenue by Type (2021-2026) & (US$ Million) Table 193. Europe Irbesartan Revenue by Type (2027-2032) & (US$ Million) Table 194. Europe Irbesartan Sales by Type (2021-2026) & (Kg) Table 195. Europe Irbesartan Sales by Type (2027-2032) & (Kg) Table 196. Europe Irbesartan Sales Price by Type (2021-2026) & (US$/Kg) Table 197. Europe Irbesartan Sales Price by Type (2027-2032) & (US$/Kg) Table 198. Europe Irbesartan Revenue by Application (2021-2026) & (US$ Million) Table 199. Europe Irbesartan Revenue by Application (2027-2032) & (US$ Million) Table 200. Europe Irbesartan Sales by Application (2021-2026) & (Kg) Table 201. Europe Irbesartan Sales by Application (2027-2032) & (Kg) Table 202. Europe Irbesartan Sales Price by Application (2021-2026) & (US$/Kg) Table 203. Europe Irbesartan Sales Price by Application (2027-2032) & (US$/Kg) Table 204. Europe Irbesartan Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. Europe Irbesartan Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. Europe Irbesartan Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. Europe Irbesartan Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 208. Europe Irbesartan Sales by Country (2021-2026) & (Kg) Table 209. Europe Irbesartan Sales by Country (2027-2032) & (Kg) Table 210. Europe Irbesartan Sales Price by Country (2021-2026) & (US$/Kg) Table 211. Europe Irbesartan Sales Price by Country (2027-2032) & (US$/Kg) Table 212. Germany Irbesartan Revenue (2021-2032) & (US$ Million) Table 213. France Irbesartan Revenue (2021-2032) & (US$ Million) Table 214. U.K. Irbesartan Revenue (2021-2032) & (US$ Million) Table 215. Italy Irbesartan Revenue (2021-2032) & (US$ Million) Table 216. Netherlands Irbesartan Revenue (2021-2032) & (US$ Million) Table 217. China Irbesartan Revenue by Type (2021-2026) & (US$ Million) Table 218. China Irbesartan Revenue by Type (2027-2032) & (US$ Million) Table 219. China Irbesartan Sales by Type (2021-2026) & (Kg) Table 220. China Irbesartan Sales by Type (2027-2032) & (Kg) Table 221. China Irbesartan Sales Price by Type (2021-2026) & (US$/Kg) Table 222. China Irbesartan Sales Price by Type (2027-2032) & (US$/Kg) Table 223. China Irbesartan Revenue by Application (2021-2026) & (US$ Million) Table 224. China Irbesartan Revenue by Application (2027-2032) & (US$ Million) Table 225. China Irbesartan Sales by Application (2021-2026) & (Kg) Table 226. China Irbesartan Sales by Application (2027-2032) & (Kg) Table 227. China Irbesartan Sales Price by Application (2021-2026) & (US$/Kg) Table 228. China Irbesartan Sales Price by Application (2027-2032) & (US$/Kg) Table 229. Asia Irbesartan Revenue by Type (2021-2026) & (US$ Million) Table 230. Asia Irbesartan Revenue by Type (2027-2032) & (US$ Million) Table 231. Asia Irbesartan Sales by Type (2021-2026) & (Kg) Table 232. Asia Irbesartan Sales by Type (2027-2032) & (Kg) Table 233. Asia Irbesartan Sales Price by Type (2021-2026) & (US$/Kg) Table 234. Asia Irbesartan Sales Price by Type (2027-2032) & (US$/Kg) Table 235. Asia Irbesartan Revenue by Application (2021-2026) & (US$ Million) Table 236. Asia Irbesartan Revenue by Application (2027-2032) & (US$ Million) Table 237. Asia Irbesartan Sales by Application (2021-2026) & (Kg) Table 238. Asia Irbesartan Sales by Application (2027-2032) & (Kg) Table 239. Asia Irbesartan Sales Price by Application (2021-2026) & (US$/Kg) Table 240. Asia Irbesartan Sales Price by Application (2027-2032) & (US$/Kg) Table 241. Asia Irbesartan Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 242. Asia Irbesartan Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 243. Asia Irbesartan Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 244. Asia Irbesartan Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 245. Asia Irbesartan Sales by Country (2021-2026) & (Kg) Table 246. Asia Irbesartan Sales by Country (2027-2032) & (Kg) Table 247. Asia Irbesartan Sales Price by Country (2021-2026) & (US$/Kg) Table 248. Asia Irbesartan Sales Price by Country (2027-2032) & (US$/Kg) Table 249. Japan Irbesartan Revenue (2021-2032) & (US$ Million) Table 250. South Korea Irbesartan Revenue (2021-2032) & (US$ Million) Table 251. India Irbesartan Revenue (2021-2032) & (US$ Million) Table 252. Australia Irbesartan Revenue (2021-2032) & (US$ Million) Table 253. China Taiwan Irbesartan Revenue (2021-2032) & (US$ Million) Table 254. Southeast Asia Irbesartan Revenue (2021-2032) & (US$ Million) Table 255. SAMEA Irbesartan Revenue by Type (2021-2026) & (US$ Million) Table 256. SAMEA Irbesartan Revenue by Type (2027-2032) & (US$ Million) Table 257. SAMEA Irbesartan Sales by Type (2021-2026) & (Kg) Table 258. SAMEA Irbesartan Sales by Type (2027-2032) & (Kg) Table 259. SAMEA Irbesartan Sales Price by Type (2021-2026) & (US$/Kg) Table 260. SAMEA Irbesartan Sales Price by Type (2027-2032) & (US$/Kg) Table 261. SAMEA Irbesartan Revenue by Application (2021-2026) & (US$ Million) Table 262. SAMEA Irbesartan Revenue by Application (2027-2032) & (US$ Million) Table 263. SAMEA Irbesartan Sales by Application (2021-2026) & (Kg) Table 264. SAMEA Irbesartan Sales by Application (2027-2032) & (Kg) Table 265. SAMEA Irbesartan Sales Price by Application (2021-2026) & (US$/Kg) Table 266. SAMEA Irbesartan Sales Price by Application (2027-2032) & (US$/Kg) Table 267. SAMEA Irbesartan Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 268. SAMEA Irbesartan Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 269. SAMEA Irbesartan Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 270. SAMEA Irbesartan Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 271. SAMEA Irbesartan Sales by Country (2021-2026) & (Kg) Table 272. SAMEA Irbesartan Sales by Country (2027-2032) & (Kg) Table 273. SAMEA Irbesartan Sales Price by Country (2021-2026) & (US$/Kg) Table 274. SAMEA Irbesartan Sales Price by Country (2027-2032) & (US$/Kg) Table 275. Brazil Irbesartan Revenue (2021-2032) & (US$ Million) Table 276. Argentina Irbesartan Revenue (2021-2032) & (US$ Million) Table 277. Chile Irbesartan Revenue (2021-2032) & (US$ Million) Table 278. Colombia Irbesartan Revenue (2021-2032) & (US$ Million) Table 279. Peru Irbesartan Revenue (2021-2032) & (US$ Million) Table 280. Saudi Arabia Irbesartan Revenue (2021-2032) & (US$ Million) Table 281. Israel Irbesartan Revenue (2021-2032) & (US$ Million) Table 282. UAE Irbesartan Revenue (2021-2032) & (US$ Million) Table 283. Turkey Irbesartan Revenue (2021-2032) & (US$ Million) Table 284. Iran Irbesartan Revenue (2021-2032) & (US$ Million) Table 285. Egypt Irbesartan Revenue (2021-2032) & (US$ Million) Table 286. Key Raw Materials Table 287. Raw Materials Key Suppliers Table 288. Irbesartan Distributors List Table 289. Irbesartan Customers List Table 290. Research Programs/Design for This Report Table 291. Authors List of This Report Table 292. Secondary Sources Table 293. Primary Sources List of Figures Figure 1. Irbesartan Image Figure 2. Global Irbesartan Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Irbesartan Market Size Share 2021 VS 2025 VS 2032 Figure 4. Combination Drugs Image Figure 5. Prescribed Drugs Image Figure 6. Global Irbesartan Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Irbesartan Market Size Share 2021 VS 2025 VS 2032 Figure 8. Heart Failure Image Figure 9. Fibrous Fibrillation Image Figure 10. Kidney Disease Image Figure 11. Hyperlipidemia Image Figure 12. High Blood Pressure Image Figure 13. Other Image Figure 14. Global Irbesartan Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Irbesartan Revenue (2021-2032) & (US$ Million) Figure 16. Global Irbesartan Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Irbesartan Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Irbesartan Revenue Market Share by Region (2021-2032) Figure 19. Global Irbesartan Sales (2021-2032) & (Kg) Figure 20. Global Irbesartan Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 21. Global Irbesartan Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Irbesartan Sales YoY (2021-2032) & (Kg) Figure 23. Europe Irbesartan Sales YoY (2021-2032) & (Kg) Figure 24. China Irbesartan Sales YoY (2021-2032) & (Kg) Figure 25. Asia (Excluding China) Irbesartan Sales YoY (2021-2032) & (Kg) Figure 26. South America, Middle East and Africa Irbesartan Sales YoY (2021-2032) & (Kg) Figure 27. Global Irbesartan Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Irbesartan Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Irbesartan Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Irbesartan Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Irbesartan Revenue Market Share by Type (2021-2032) Figure 33. Global Irbesartan Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 34. Global Irbesartan Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Irbesartan Sales Market Share by Type (2021-2032) Figure 36. Global Irbesartan Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Irbesartan Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Irbesartan Revenue Market Share by Application (2021-2032) Figure 39. Global Irbesartan Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 40. Global Irbesartan Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Irbesartan Sales Market Share by Application (2021-2032) Figure 42. North America Irbesartan Revenue Share by Type (2021-2032) Figure 43. North America Irbesartan Sales Share by Type (2021-2032) Figure 44. North America Irbesartan Revenue Share by Application (2021-2032) Figure 45. North America Irbesartan Sales Share by Application (2021-2032) Figure 46. North America Irbesartan Revenue Share by Country (2021-2032) Figure 47. North America Irbesartan Sales Share by Country (2021-2032) Figure 48. Europe Irbesartan Revenue Share by Type (2021-2032) Figure 49. Europe Irbesartan Sales Share by Type (2021-2032) Figure 50. Europe Irbesartan Revenue Share by Application (2021-2032) Figure 51. Europe Irbesartan Sales Share by Application (2021-2032) Figure 52. Europe Irbesartan Revenue Share by Country (2021-2032) Figure 53. Europe Irbesartan Sales Share by Country (2021-2032) Figure 54. China Irbesartan Revenue Share by Type (2021-2032) Figure 55. China Irbesartan Sales Share by Type (2021-2032) Figure 56. China Irbesartan Revenue Share by Application (2021-2032) Figure 57. China Irbesartan Sales Share by Application (2021-2032) Figure 58. Asia Irbesartan Revenue Share by Type (2021-2032) Figure 59. Asia Irbesartan Sales Share by Type (2021-2032) Figure 60. Asia Irbesartan Revenue Share by Application (2021-2032) Figure 61. Asia Irbesartan Sales Share by Application (2021-2032) Figure 62. Asia Irbesartan Revenue Share by Country (2021-2032) Figure 63. Asia Irbesartan Sales Share by Country (2021-2032) Figure 64. SAMEA Irbesartan Revenue Share by Type (2021-2032) Figure 65. SAMEA Irbesartan Sales Share by Type (2021-2032) Figure 66. SAMEA Irbesartan Revenue Share by Application (2021-2032) Figure 67. SAMEA Irbesartan Sales Share by Application (2021-2032) Figure 68. SAMEA Irbesartan Revenue Share by Country (2021-2032) Figure 69. SAMEA Irbesartan Sales Share by Country (2021-2032) Figure 70. Irbesartan Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Irbesartan Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Combination Drugs
  • Prescribed Drugs
Applications
  • Heart Failure
  • Fibrous Fibrillation
  • Kidney Disease
  • Hyperlipidemia
  • High Blood Pressure
  • Other
Companies covered
  • Angita Pharma
  • Apotex
  • Auro Pharma
  • Avanstra
  • BMS
  • Hanall
  • Shionogi
  • Sumitomo Dainippon Pharma
  • Taj Pharmaceuticals
  • Verdant Life Sciences
  • Jiangsu Hengrui Medicine
  • Jiangsu Wangao Pharmaceutical
  • CTTQ
  • Novartis
  • Sanofi
  • Teva
  • Tianjin Huairen Pharmaceutical
  • Xiansheng Pharmaceutical
  • Yuanhe Pharmaceutical
  • Zhejiang Ainuo Pharmaceutical
  • Zhejiang Huahai Pharmaceutical
  • Zhuhai Rundu Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Irbesartan Market by Type
  3. 1.2.1 Global Irbesartan Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Combination Drugs
  5. 1.2.3 Prescribed Drugs
  6. 1.3 Irbesartan Market by Application
  7. 1.3.1 Global Irbesartan Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Heart Failure
  9. 1.3.3 Fibrous Fibrillation
  10. 1.3.4 Kidney Disease
  11. 1.3.5 Hyperlipidemia
  12. 1.3.6 High Blood Pressure
  13. 1.3.7 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Irbesartan Market Dynamics
  1. 2.1 Irbesartan Industry Trends
  2. 2.2 Irbesartan Industry Drivers
  3. 2.3 Irbesartan Industry Opportunities and Challenges
  4. 2.4 Irbesartan Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Irbesartan Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Irbesartan Revenue by Region
  3. 3.2.1 Global Irbesartan Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Irbesartan Revenue by Region (2021-2026)
  5. 3.2.3 Global Irbesartan Revenue by Region (2027-2032)
  6. 3.2.4 Global Irbesartan Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Irbesartan Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Irbesartan Sales by Region
  9. 3.4.1 Global Irbesartan Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Irbesartan Sales by Region (2021-2026)
  11. 3.4.3 Global Irbesartan Sales by Region (2027-2032)
  12. 3.4.4 Global Irbesartan Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Irbesartan Revenue by Manufacturers
  2. 4.1.1 Global Irbesartan Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Irbesartan Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Irbesartan Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Irbesartan Sales by Manufacturers
  6. 4.2.1 Global Irbesartan Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Irbesartan Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Irbesartan Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Irbesartan Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Irbesartan Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Irbesartan Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Irbesartan Manufacturers, Product Type & Application
  13. 4.7 Global Irbesartan Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Irbesartan Market CR5 and HHI
  16. 4.8.2 2025 Irbesartan Tier 1, Tier 2, and Tier 3
5 Irbesartan Market by Type
  1. 5.1 Global Irbesartan Revenue by Type
  2. 5.1.1 Global Irbesartan Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Irbesartan Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Irbesartan Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Irbesartan Sales by Type
  6. 5.2.1 Global Irbesartan Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Irbesartan Sales by Type (2021-2032) & (Kg)
  8. 5.2.3 Global Irbesartan Sales Market Share by Type (2021-2032)
  9. 5.3 Global Irbesartan Price by Type
6 Irbesartan Market by Application
  1. 6.1 Global Irbesartan Revenue by Application
  2. 6.1.1 Global Irbesartan Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Irbesartan Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Irbesartan Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Irbesartan Sales by Application
  6. 6.2.1 Global Irbesartan Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Irbesartan Sales by Application (2021-2032) & (Kg)
  8. 6.2.3 Global Irbesartan Sales Market Share by Application (2021-2032)
  9. 6.3 Global Irbesartan Price by Application
7 Company Profiles
  1. 7.1 Angita Pharma
  2. 7.1.1 Angita Pharma Company Information
  3. 7.1.2 Angita Pharma Business Overview
  4. 7.1.3 Angita Pharma Irbesartan Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Angita Pharma Irbesartan Product Portfolio
  6. 7.1.5 Angita Pharma Recent Developments
  7. 7.2 Apotex
  8. 7.2.1 Apotex Company Information
  9. 7.2.2 Apotex Business Overview
  10. 7.2.3 Apotex Irbesartan Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Apotex Irbesartan Product Portfolio
  12. 7.2.5 Apotex Recent Developments
  13. 7.3 Auro Pharma
  14. 7.3.1 Auro Pharma Company Information
  15. 7.3.2 Auro Pharma Business Overview
  16. 7.3.3 Auro Pharma Irbesartan Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Auro Pharma Irbesartan Product Portfolio
  18. 7.3.5 Auro Pharma Recent Developments
  19. 7.4 Avanstra
  20. 7.4.1 Avanstra Company Information
  21. 7.4.2 Avanstra Business Overview
  22. 7.4.3 Avanstra Irbesartan Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Avanstra Irbesartan Product Portfolio
  24. 7.4.5 Avanstra Recent Developments
  25. 7.5 BMS
  26. 7.5.1 BMS Company Information
  27. 7.5.2 BMS Business Overview
  28. 7.5.3 BMS Irbesartan Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 BMS Irbesartan Product Portfolio
  30. 7.5.5 BMS Recent Developments
  31. 7.6 Hanall
  32. 7.6.1 Hanall Company Information
  33. 7.6.2 Hanall Business Overview
  34. 7.6.3 Hanall Irbesartan Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Hanall Irbesartan Product Portfolio
  36. 7.6.5 Hanall Recent Developments
  37. 7.7 Shionogi
  38. 7.7.1 Shionogi Company Information
  39. 7.7.2 Shionogi Business Overview
  40. 7.7.3 Shionogi Irbesartan Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Shionogi Irbesartan Product Portfolio
  42. 7.7.5 Shionogi Recent Developments
  43. 7.8 Sumitomo Dainippon Pharma
  44. 7.8.1 Sumitomo Dainippon Pharma Company Information
  45. 7.8.2 Sumitomo Dainippon Pharma Business Overview
  46. 7.8.3 Sumitomo Dainippon Pharma Irbesartan Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Sumitomo Dainippon Pharma Irbesartan Product Portfolio
  48. 7.8.5 Sumitomo Dainippon Pharma Recent Developments
  49. 7.9 Taj Pharmaceuticals
  50. 7.9.1 Taj Pharmaceuticals Company Information
  51. 7.9.2 Taj Pharmaceuticals Business Overview
  52. 7.9.3 Taj Pharmaceuticals Irbesartan Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Taj Pharmaceuticals Irbesartan Product Portfolio
  54. 7.9.5 Taj Pharmaceuticals Recent Developments
  55. 7.10 Verdant Life Sciences
  56. 7.10.1 Verdant Life Sciences Company Information
  57. 7.10.2 Verdant Life Sciences Business Overview
  58. 7.10.3 Verdant Life Sciences Irbesartan Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Verdant Life Sciences Irbesartan Product Portfolio
  60. 7.10.5 Verdant Life Sciences Recent Developments
  61. 7.11 Jiangsu Hengrui Medicine
  62. 7.11.1 Jiangsu Hengrui Medicine Company Information
  63. 7.11.2 Jiangsu Hengrui Medicine Business Overview
  64. 7.11.3 Jiangsu Hengrui Medicine Irbesartan Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Jiangsu Hengrui Medicine Irbesartan Product Portfolio
  66. 7.11.5 Jiangsu Hengrui Medicine Recent Developments
  67. 7.12 Jiangsu Wangao Pharmaceutical
  68. 7.12.1 Jiangsu Wangao Pharmaceutical Company Information
  69. 7.12.2 Jiangsu Wangao Pharmaceutical Business Overview
  70. 7.12.3 Jiangsu Wangao Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Jiangsu Wangao Pharmaceutical Irbesartan Product Portfolio
  72. 7.12.5 Jiangsu Wangao Pharmaceutical Recent Developments
  73. 7.13 CTTQ
  74. 7.13.1 CTTQ Company Information
  75. 7.13.2 CTTQ Business Overview
  76. 7.13.3 CTTQ Irbesartan Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 CTTQ Irbesartan Product Portfolio
  78. 7.13.5 CTTQ Recent Developments
  79. 7.14 Novartis
  80. 7.14.1 Novartis Company Information
  81. 7.14.2 Novartis Business Overview
  82. 7.14.3 Novartis Irbesartan Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Novartis Irbesartan Product Portfolio
  84. 7.14.5 Novartis Recent Developments
  85. 7.15 Sanofi
  86. 7.15.1 Sanofi Company Information
  87. 7.15.2 Sanofi Business Overview
  88. 7.15.3 Sanofi Irbesartan Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Sanofi Irbesartan Product Portfolio
  90. 7.15.5 Sanofi Recent Developments
  91. 7.16 Teva
  92. 7.16.1 Teva Company Information
  93. 7.16.2 Teva Business Overview
  94. 7.16.3 Teva Irbesartan Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Teva Irbesartan Product Portfolio
  96. 7.16.5 Teva Recent Developments
  97. 7.17 Tianjin Huairen Pharmaceutical
  98. 7.17.1 Tianjin Huairen Pharmaceutical Company Information
  99. 7.17.2 Tianjin Huairen Pharmaceutical Business Overview
  100. 7.17.3 Tianjin Huairen Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Tianjin Huairen Pharmaceutical Irbesartan Product Portfolio
  102. 7.17.5 Tianjin Huairen Pharmaceutical Recent Developments
  103. 7.18 Xiansheng Pharmaceutical
  104. 7.18.1 Xiansheng Pharmaceutical Company Information
  105. 7.18.2 Xiansheng Pharmaceutical Business Overview
  106. 7.18.3 Xiansheng Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Xiansheng Pharmaceutical Irbesartan Product Portfolio
  108. 7.18.5 Xiansheng Pharmaceutical Recent Developments
  109. 7.19 Yuanhe Pharmaceutical
  110. 7.19.1 Yuanhe Pharmaceutical Company Information
  111. 7.19.2 Yuanhe Pharmaceutical Business Overview
  112. 7.19.3 Yuanhe Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Yuanhe Pharmaceutical Irbesartan Product Portfolio
  114. 7.19.5 Yuanhe Pharmaceutical Recent Developments
  115. 7.20 Zhejiang Ainuo Pharmaceutical
  116. 7.20.1 Zhejiang Ainuo Pharmaceutical Company Information
  117. 7.20.2 Zhejiang Ainuo Pharmaceutical Business Overview
  118. 7.20.3 Zhejiang Ainuo Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Zhejiang Ainuo Pharmaceutical Irbesartan Product Portfolio
  120. 7.20.5 Zhejiang Ainuo Pharmaceutical Recent Developments
  121. 7.21 Zhejiang Huahai Pharmaceutical
  122. 7.21.1 Zhejiang Huahai Pharmaceutical Company Information
  123. 7.21.2 Zhejiang Huahai Pharmaceutical Business Overview
  124. 7.21.3 Zhejiang Huahai Pharmaceutical Irbesartan Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Zhejiang Huahai Pharmaceutical Irbesartan Product Portfolio
  126. 7.21.5 Zhejiang Huahai Pharmaceutical Recent Developments
  127. 7.22 Zhuhai Rundu Pharma
  128. 7.22.1 Zhuhai Rundu Pharma Company Information
  129. 7.22.2 Zhuhai Rundu Pharma Business Overview
  130. 7.22.3 Zhuhai Rundu Pharma Irbesartan Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Zhuhai Rundu Pharma Irbesartan Product Portfolio
  132. 7.22.5 Zhuhai Rundu Pharma Recent Developments
8 North America
  1. 8.1 North America Irbesartan Market Size by Type
  2. 8.1.1 North America Irbesartan Revenue by Type (2021-2032)
  3. 8.1.2 North America Irbesartan Sales by Type (2021-2032)
  4. 8.1.3 North America Irbesartan Price by Type (2021-2032)
  5. 8.2 North America Irbesartan Market Size by Application
  6. 8.2.1 North America Irbesartan Revenue by Application (2021-2032)
  7. 8.2.2 North America Irbesartan Sales by Application (2021-2032)
  8. 8.2.3 North America Irbesartan Price by Application (2021-2032)
  9. 8.3 North America Irbesartan Market Size by Country
  10. 8.3.1 North America Irbesartan Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Irbesartan Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Irbesartan Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Irbesartan Market Size by Type
  2. 9.1.1 Europe Irbesartan Revenue by Type (2021-2032)
  3. 9.1.2 Europe Irbesartan Sales by Type (2021-2032)
  4. 9.1.3 Europe Irbesartan Price by Type (2021-2032)
  5. 9.2 Europe Irbesartan Market Size by Application
  6. 9.2.1 Europe Irbesartan Revenue by Application (2021-2032)
  7. 9.2.2 Europe Irbesartan Sales by Application (2021-2032)
  8. 9.2.3 Europe Irbesartan Price by Application (2021-2032)
  9. 9.3 Europe Irbesartan Market Size by Country
  10. 9.3.1 Europe Irbesartan Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Irbesartan Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Irbesartan Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Irbesartan Market Size by Type
  2. 10.1.1 China Irbesartan Revenue by Type (2021-2032)
  3. 10.1.2 China Irbesartan Sales by Type (2021-2032)
  4. 10.1.3 China Irbesartan Price by Type (2021-2032)
  5. 10.2 China Irbesartan Market Size by Application
  6. 10.2.1 China Irbesartan Revenue by Application (2021-2032)
  7. 10.2.2 China Irbesartan Sales by Application (2021-2032)
  8. 10.2.3 China Irbesartan Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Irbesartan Market Size by Type
  2. 11.1.1 Asia Irbesartan Revenue by Type (2021-2032)
  3. 11.1.2 Asia Irbesartan Sales by Type (2021-2032)
  4. 11.1.3 Asia Irbesartan Price by Type (2021-2032)
  5. 11.2 Asia Irbesartan Market Size by Application
  6. 11.2.1 Asia Irbesartan Revenue by Application (2021-2032)
  7. 11.2.2 Asia Irbesartan Sales by Application (2021-2032)
  8. 11.2.3 Asia Irbesartan Price by Application (2021-2032)
  9. 11.3 Asia Irbesartan Market Size by Country
  10. 11.3.1 Asia Irbesartan Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Irbesartan Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Irbesartan Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Irbesartan Market Size by Type
  2. 12.1.1 SAMEA Irbesartan Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Irbesartan Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Irbesartan Price by Type (2021-2032)
  5. 12.2 SAMEA Irbesartan Market Size by Application
  6. 12.2.1 SAMEA Irbesartan Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Irbesartan Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Irbesartan Price by Application (2021-2032)
  9. 12.3 SAMEA Irbesartan Market Size by Country
  10. 12.3.1 SAMEA Irbesartan Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Irbesartan Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Irbesartan Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Irbesartan Value Chain Analysis
  2. 13.1.1 Irbesartan Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Irbesartan Production Mode & Process
  6. 13.2 Irbesartan Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Irbesartan Distributors
  9. 13.2.3 Irbesartan Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst